Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Hematology

What Causes Erythromelalgia in Essential Thrombocythemia?

At a Glance

In essential thrombocythemia, excess or hyperactive platelets can clump in the tiny blood vessels of the hands and feet, reducing oxygen and causing erythromelalgia—burning pain, heat, and redness. Low-dose aspirin can help when prescribed safely.

Erythromelalgia is a clinical syndrome where the hands and feet become intensely hot, red, and painful. While it can have other causes (such as nerve problems or medication reactions), in people with essential thrombocythemia (ET), it often occurs as a microvascular complication. This happens because the high number of sticky platelets produced in ET can clump together and interfere with blood flow in the tiny blood vessels of your extremities [1].

When to Seek Urgent Medical Care

Not all pain or color changes are erythromelalgia. Seek emergency medical attention if you experience:

  • A finger or toe that suddenly becomes cold, pale, blue, or black.
  • Severe, escalating pain, especially on only one side.
  • Numbness, weakness, or new skin sores/ulcers.
  • Signs of severe bleeding, such as nosebleeds that won’t stop, unusual or extensive bruising, or black/tarry stools.

The Microvascular Mechanism

In ET, your bone marrow produces too many platelets, and these platelets are often hyperactive. When they circulate through the body’s smallest blood vessels (like those in your fingers and toes), they can stick together to form microscopic blockages [1].

This clumping restricts normal blood flow, leading to a lack of oxygen in the surrounding tissues called ischemia [2]. This ischemic stress, combined with abnormal nerve signaling and widened blood vessels, is a leading explanation for the hallmark burning pain, warmth, and redness that you experience [2][3].

Important Note on Cooling

Many patients instinctively try to cool their burning hands or feet. Do not use ice packs or soak your extremities in ice water. Extreme cold can severely damage your already vulnerable skin and cause ulcers or tissue damage. Ask your care team for safer ways to cool your skin.

Management with Low-Dose Aspirin

For many ET patients, low-dose aspirin (typically 81 to 100 mg daily) is recommended to manage erythromelalgia, provided there are no contraindications [4]. Aspirin works by making the platelets less sticky, which helps prevent them from clumping in small blood vessels. While some patients experience very rapid relief, aspirin does not lower your platelet count and it is not safe for everyone [5]. You should only start or adjust aspirin under your doctor’s supervision, as they must consider your history of bleeding, allergies, and other medications [6].

When Symptoms Persist Before the Next Dose

Because ET causes rapid production of new platelets, the anti-clumping effect of a once-daily aspirin might wear off before 24 hours have passed [7]. If your symptoms consistently return later in the day, your specialist might consider a twice-daily aspirin schedule to improve ongoing platelet inhibition [8]. This is not a routine adjustment and requires careful medical evaluation.

Do not increase your aspirin dose on your own. Having an extremely high platelet count can paradoxically interfere with a vital clotting protein, increasing your risk of bleeding—a condition known as acquired von Willebrand syndrome (AVWS) [9][10]. A high platelet count alone does not confirm AVWS; your doctor will use specific blood tests and your bleeding history to determine if it is safe to adjust your aspirin [10].

Role of Cytoreductive Therapy

If symptoms are difficult to control, your doctor may recommend cytoreductive therapy—medicines that reduce excessive blood-cell production [11]. Options include hydroxyurea, interferons, or other medications, chosen based on your age, overall clotting risk, and pregnancy plans [6]. Lowering your overall platelet count reduces the number of platelets available to block blood vessels, which helps treat the underlying cause of your symptoms and can make aspirin more effective [12]. These medications require regular blood-count monitoring.

Common questions in this guide

Why can essential thrombocythemia cause burning hands and feet?
Essential thrombocythemia produces too many platelets, and those platelets may be unusually active and sticky. They can clump in the tiny blood vessels of the hands and feet, reducing blood flow and oxygen to nearby tissue. This can trigger the heat, redness, and burning pain of erythromelalgia.
Can aspirin relieve erythromelalgia caused by ET?
For many people with ET, prescribed low-dose aspirin reduces platelet stickiness and may quickly ease erythromelalgia. It does not lower the platelet count, and it is not safe for everyone because bleeding risk, allergies, drug interactions, and acquired von Willebrand syndrome may matter. Start or change it only after review by your clinician.
Why might my symptoms return before my next aspirin dose?
ET can produce new platelets quickly, so the platelet-inhibiting effect of one daily aspirin dose may not last through the full day for some people. A specialist may consider a twice-daily schedule, but this is not routine and must be based on bleeding risk and blood-test results. Do not take extra aspirin on your own.
Is it safe to cool burning hands and feet with ice?
No. Ice packs and ice-water soaks can damage skin that is already vulnerable from reduced small-vessel blood flow and may cause ulcers or other tissue injury. Ask your care team for safer ways to cool the skin.
When should ET-related burning or color changes be treated as an emergency?
Seek emergency care if a finger or toe suddenly becomes cold, pale, blue, or black; if pain is severe, rapidly worsening, or mainly on one side; or if you develop numbness, weakness, or a new sore or ulcer. Get urgent help for severe bleeding, such as a nosebleed that will not stop, extensive bruising, or black, tarry stools.
What happens if aspirin does not control erythromelalgia in essential thrombocythemia?
Your doctor may recommend cytoreductive therapy, which reduces excessive blood-cell production and lowers the platelet count. Options mentioned for ET include hydroxyurea, interferons, and other medicines. These treatments require regular blood-count monitoring and are selected based on factors such as age, clotting risk, and pregnancy plans.
Why might my doctor test for acquired von Willebrand syndrome before changing aspirin?
Very high platelet counts can interfere with a clotting protein, causing acquired von Willebrand syndrome and increasing bleeding risk. A high platelet count alone does not diagnose this problem; clinicians use specific blood tests and your bleeding history before deciding whether an aspirin change is safe.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my current aspirin dose providing ongoing protection against platelet clumping, or should we consider a twice-daily schedule?
  2. 2.Are my symptoms purely erythromelalgia, or could they indicate a more severe circulation problem?
  3. 3.Should I be tested for acquired von Willebrand syndrome before making any changes to my aspirin dose?
  4. 4.Do my current symptoms suggest we need to adjust or start cytoreductive therapy to lower my overall platelet count?
  5. 5.Are there any over-the-counter medicines (like ibuprofen) that I should avoid to prevent increasing my bleeding risk?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Thrombocytosis: Rapid Evidence Review.

    Williams PM, Williams AL

    American family physician 2026; (113(4)):332-338.

    PMID: 42101597
  2. 2

    Erythromelalgia: a cutaneous manifestation of neuropathy?

    Leroux MB

    Anais brasileiros de dermatologia 2018; (93(1)):86-94 doi:10.1590/abd1806-4841.20187535.

    PMID: 29641704
  3. 3

    The Cutaneous Pathology of Erythromelalgia and Its Role in Establishing Critical Clues Regarding Pathogenesis.

    Magro C, Kalomeris T, Guo L

    The American Journal of dermatopathology 2025; (47(3)):184-190 doi:10.1097/DAD.0000000000002912.

    PMID: 39846717
  4. 4

    Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?

    Cattaneo M

    Haematologica 2023; (108(6)):1487-1499 doi:10.3324/haematol.2022.281388.

    PMID: 36632735
  5. 5

    Digital gangrene: can be the first manifestation of essential thrombocythemia? a case report.

    Mirhosseini A, Bozorgmehr R, Bastan F, Rashidian M

    Annals of medicine and surgery (2012) 2024; (86(2)):1200-1204 doi:10.1097/MS9.0000000000001671.

    PMID: 38333237
  6. 6

    Contemporary management of essential thrombocythemia in children.

    Randi ML, Bertozzi I, Putti MC

    Expert review of hematology 2019; (12(5)):367-373 doi:10.1080/17474086.2019.1602034.

    PMID: 30925843
  7. 7

    A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.

    Rocca B, Tosetto A, Betti S, et al.

    Blood 2020; (136(2)):171-182 doi:10.1182/blood.2019004596.

    PMID: 32266380
  8. 8

    Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.

    Rocca B, Tosetto A, Petrucci G, et al.

    American journal of hematology 2024; (99(8)):1462-1474 doi:10.1002/ajh.27418.

    PMID: 38877813
  9. 9

    Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia.

    Janjetovic S, Rolling CC, Budde U, et al.

    Thrombosis research 2022; (218()):35-43 doi:10.1016/j.thromres.2022.08.002.

    PMID: 35988442
  10. 10

    Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome: only pertinent at diagnosis?

    Lemarié F, Picard J, Galinat H, et al.

    Research and practice in thrombosis and haemostasis 2026; (10(5)):106858 doi:10.1016/j.rpth.2026.106858.

    PMID: 42576955
  11. 11

    Cytoreduction for ET and PV: who, what, when, and how?

    Tremblay D

    Hematology. American Society of Hematology. Education Program 2023; (2023(1)):660-666 doi:10.1182/hematology.2023000451.

    PMID: 38066871
  12. 12

    Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms.

    Perrier-Cornet A, Ianotto JC, Mingant F, et al.

    Platelets 2018; (29(7)):723-728 doi:10.1080/09537104.2017.1361018.

    PMID: 29090588

This page explains why erythromelalgia can occur with essential thrombocythemia for informational purposes only and does not constitute medical advice. Do not start, stop, or change aspirin or other treatment without guidance from your care team, and seek urgent care for warning signs.

Get notified when new evidence is published on Essential thrombocythemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.